Ryoma Yokoi

Gifu-shi, 5011194, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

A case of rectal mixed neuroendocrine-non-neuroendocrine neoplasm diagnosed only after radical surgery: implications of diagnostic timing for therapeutic decision-making.

A case of rectal mixed neuroendocrine-non-neuroendocrine neoplasm diagnosed only after radical surgery: implications of diagnostic timing for therapeutic decision-making.

Journal: Clinical journal of gastroenterology

Published: July 07, 2026

A Case of Cecal Mixed Neuroendocrine-Non-Neuroendocrine Neoplasm Requiring Adjuvant Chemotherapy Based on Comprehensive Pathological Assessment.

A Case of Cecal Mixed Neuroendocrine-Non-Neuroendocrine Neoplasm Requiring Adjuvant Chemotherapy Based on Comprehensive Pathological Assessment.

Journal: Surgical case reports

Published: June 03, 2026

Conduit size and the risk of delayed gastric conduit emptying after esophagectomy.

Conduit size and the risk of delayed gastric conduit emptying after esophagectomy.

Journal: Surgery today

Published: February 23, 2026

Decreased Expression by a Chemically Modified siRNA to PTBP1 Seriously Affects Warburg Effect in Colorectal Cancer Cells.

Decreased Expression by a Chemically Modified siRNA to PTBP1 Seriously Affects Warburg Effect in Colorectal Cancer Cells.

Journal: Cancer science

Published: January 19, 2026

Fusion surgery in robot-assisted esophagectomy: stepwise learning curves across the da Vinci™ and hinotori™ platforms.

Fusion surgery in robot-assisted esophagectomy: stepwise learning curves across the da Vinci™ and hinotori™ platforms.

Journal: World journal of surgical oncology

Published: December 18, 2025

Clinical significance and predictive factors of delayed gastric conduit emptying after esophagectomy.

Clinical significance and predictive factors of delayed gastric conduit emptying after esophagectomy.

Journal: Surgery today

Published: November 25, 2025

TAS-102 plus bevacizumab as salvage treatment in colorectal cancer: A retrospective study.

TAS-102 plus bevacizumab as salvage treatment in colorectal cancer: A retrospective study.

Journal: Oncology letters

Published: August 08, 2025

Association between FGF10 expression and gland-forming differentiation pattern in gastric adenocarcinoma: An immunohistochemical analysis.

Association between FGF10 expression and gland-forming differentiation pattern in gastric adenocarcinoma: An immunohistochemical analysis.

Journal: Oncology letters

Published: May 31, 2025

Prognostic impact of syndecan-1 expression and serum concentration in colorectal cancer.

Prognostic impact of syndecan-1 expression and serum concentration in colorectal cancer.

Journal: Oncology letters

Published: March 22, 2025

Single-molecule imaging quantifies oncogenic KRAS dynamics for enhanced accuracy of therapeutic efficacy assessment.

Single-molecule imaging quantifies oncogenic KRAS dynamics for enhanced accuracy of therapeutic efficacy assessment.

Journal: iScience

Published: February 16, 2025

Evaluating glycocalyx morphology and composition in frozen and formalin-fixed liver tumor sections.

Evaluating glycocalyx morphology and composition in frozen and formalin-fixed liver tumor sections.

Journal: Pathology, research and practice

Published: July 29, 2024

Neutrophil‑to‑lymphocyte ratio and risk of disease progression in patients with nivolumab‑treated unresectable or recurrent gastric cancer.

Neutrophil‑to‑lymphocyte ratio and risk of disease progression in patients with nivolumab‑treated unresectable or recurrent gastric cancer.

Journal: Oncology letters

Published: June 16, 2024

Showing 1-12 of 28

Last Updated: 09/26/2026